MLchartDataset catalogue

Reverse dosimetry

Term · Environment · MLC-T-ENV-024249

Uses human pharmacokinetic models to convert biomarker measurements to dose levels that are comparable to an RfD or other dose-based toxicity value. [NRC, 2006; U.S. EPA Biomonitoring - An Exposure Science Tool for Exposure and Risk Assessment (https://cfpub.epa.gov/ncea/risk/hhra/recordisplay.cfm?deid=243731)]

Table 1. Record
IdentifierMLC-T-ENV-024249
FieldEnvironment
ReferencesEPA ExpoBox Terminology
Record as JSON 
{
  "id": "MLC-T-ENV-024249",
  "term": "Reverse dosimetry",
  "field": "Environment",
  "definition": "Uses human pharmacokinetic models to convert biomarker measurements to dose levels that are comparable to an RfD or other dose-based toxicity value. [NRC, 2006; U.S. EPA Biomonitoring - An Exposure Science Tool for Exposure and Risk Assessment (https://cfpub.epa.gov/ncea/risk/hhra/recordisplay.cfm?deid=243731)]",
  "references": [
    "EPA ExpoBox Terminology"
  ],
  "url": "https://mlchart.com/terminology/environment/reverse-dosimetry/"
}

Record 24,249 of 30,736 in Environment terminology (MLC-0121). Request the full dataset.